Vimarsana
Biggest News Aggregation in the World

Page 18 - Intern Med News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intern Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intern Med Today - Breaking & Trending Today

"If the data doesn't exist to support your hypothesis, you simply spin the results as if it did" – Prof. Noakes on Keys' Cholesterol Con - Vimarsana News

"If the data doesn't exist to support your hypothesis, you simply spin the results as if it did" – Prof. Noakes on Keys' Cholesterol Con

Noakes continues with the tale of Keys’ cholesterol con, picking up in 1979, when the results of the Helsinki Policemen Study were published.

Do Medical Masks Match N95s for COVID Protection in Healthcare Settings? - Vimarsana News

Do Medical Masks Match N95s for COVID Protection in Healthcare Settings?

'Generous' noninferiority threshold met, but could be unacceptable to many, says editorialist

Systemic sclerosis - Vimarsana News

Systemic sclerosis

Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue disease. Once considered an untreatable and unpredictable condition, research advancements have improved our understanding of its disease pathogenesis and clinical phenotypes and expanded our treatment armamentarium. Early and accurate diagnosis is essential, while ongoing efforts to risk stratify patients have a central role in predicting both organ involvement and disease progression. A holistic approach is required when choosing the optimal therapeutic strategy, balancing the side-effect profil...

Type 2 diabetes - Vimarsana News

Type 2 diabetes

Type 2 diabetes accounts for nearly 90% of the approximately 537 million cases of diabetes worldwide. The number affected is increasing rapidly with alarming trends in children and young adults (up to age 40 years). Early detection and proactive management are crucial for prevention and mitigation of microvascular and macrovascular complications and mortality burden. Access to novel therapies improves person-centred outcomes beyond glycaemic control. Precision medicine, including multiomics and pharmacogenomics, hold promise to enhance understanding of disease heterogeneity, leading to targete...

Monoclonals for COVID in Pregnancy Pass Safety Test, Efficacy on the Other Hand ... - Vimarsana News

Monoclonals for COVID in Pregnancy Pass Safety Test, Efficacy on the Other Hand ...

AEs were mild and rare; no difference in composite outcome including COVID hospitalization